ADTX vs XYL · rev $3.2K vs P/E 27, rev $4.46B
Aditxt Inc. (ADTX) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Aditxt Inc. (ADTX) is a biotechnology company listed on NASDAQ.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported ADTX revenue for 2025-12-31 was $3.2K. Net income was -$43.1M. Revenue was down 97.6% from 2024-12-31 to 2025-12-31. ADTX currently screens at market cap $3.6K.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
ADTX currently screens at market cap $3.6K. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the ADTX and XYL stock pages for the full models.
Not investment advice.